RESEARCH
27 Feb 2026
INNOVATION
25 Feb 2026
PARTNERSHIPS
24 Feb 2026
INVESTMENT
23 Feb 2026

INNOVATION
20 Feb 2026
Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections

INVESTMENT
9 Feb 2026
Recent large early-stage raises, led by Alveus at $159.8M, highlight rising competition with Novo Nordisk and Eli Lilly

INNOVATION
6 Feb 2026
Grace and Molecule.one apply AI and automation to ease peptide bottlenecks, signaling a shift toward faster, more resilient US drug manufa...

MARKET TRENDS
5 Feb 2026
Soaring demand is forcing peptide drugmakers to rethink strategy, shifting focus from discovery toward manufacturing scale, reliability, a...

TECHNOLOGY
4 Feb 2026
Generative AI platforms like Menten AI’s MAUD 1.0 are speeding early peptide discovery, helping biotech firms make smarter design decision...

PARTNERSHIPS
3 Feb 2026
Completed in Nov 2025, the Salarius and Decoy deal creates Decoy Therapeutics with $14M and an AI-first peptide platform

INSIGHTS
2 Feb 2026
Peptide therapies advance into pivotal Phase 2/3 trials, pointing to a new way to prevent implant infections if results and approvals foll...
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.